Changes in object recognition and anxiety-like behaviour in mice expressing a Cx47 mutation that causes pelizaeus-merzbacher-like disease

Developmental Neuroscience

Volumn 34, Issue 2-3, 2012, Pages 277-287

  Zlomuzica, Armin ^a,b   Tress, Oliver ^c   Binder, Sonja ^a   Rovira, Catherine ^d   Willecke, Klaus ^c   Dere, Ekrem ^a,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Connexin 47; Cx47M282T mice; Gap junctions; GJC2; Leucoencephalopathy; Novel object recognition; Oligodendrocytes; Pelizaeus Merzbacher like disease

Indexed keywords

CONNEXIN 47;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; GENOTYPE; LEARNING; MAZE TEST; MISSENSE MUTATION; MOTONEURON; MOTOR COORDINATION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOGNITION; SPATIAL MEMORY; WORKING MEMORY;

AGE FACTORS; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CONNEXINS; DISEASE MODELS, ANIMAL; GAP JUNCTIONS; MEMORY, SHORT-TERM; MICE; MUTATION; PELIZAEUS-MERZBACHER DISEASE; RECOGNITION (PSYCHOLOGY);

EID: 84866290371     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000339305     Document Type: Article

References (60)

1. Söhl G, Maxeiner S, Willecke K: Expression and functions of neuronal gap junctions. Nat Rev Neurosci 2005; 6: 191-200.
2. Kumar NM, Gilula NB: The gap junction communication channel. Cell 1996; 84: 381- 388.
3. Söhl G, Willecke K: An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes 2003; 10: 173-180.
4. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, Deutsch U, Söhl G: Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002; 383: 725-737.
5. Söhl G, Willecke K: Gap junctions and the connexin protein family. Cardiovasc Res 2004; 62: 228-232.
6. Kleopa KA, Orthmann JL, Enriquez A, Paul DL, Scherer SS: Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes. Glia 2004; 47: 346-357.
7. Li X, Ionescu AV, Lynn BD, Lu S, Kamasawa N, Morita M, Davidson KG, Yasumura T, Rash JE, Nagy JI: Connexin47, connexin29 and connexin32 co-expression in oligodendrocytes and Cx47 association with zonula occludens-1 (ZO-1) in mouse brain. Neuroscience 2004; 126: 611-630.
8. Menichella DM, Goodenough DA, Sirkowski E, Scherer SS, Paul DL: Connexins are critical for normal myelination in the CNS. J Neurosci 2003; 23: 5963-5973.
9. Odermatt B, Wellershaus K, Wallraff A, Seifert G, Degen J, Euwens C, Fuss B, Büssow H, Schilling K, Steinhäuser C, Willecke K: Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. J Neurosci 2003; 23: 4549-4559.
10. Altevogt BM, Kleopa KA, Postma FR, Scherer SS, Paul DL: Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J Neurosci 2002; 22: 6458-6470.
11. Li J, Habbes HW, Eiberger J, Willecke K, Dermietzel R, Meier C: Analysis of connexin expression during mouse Schwann cell development identifies connexin29 as a novel marker for the transition of neural crest to precursor cells. Glia 2007; 55: 93-103.
12. Maglione M, Tress O, Haas B, Karram K, Trotter J, Willecke K, Kettenmann H: Oligodendrocytes in mouse corpus callosum are coupled via gap junction channels formed by connexin47 and connexin32. Glia 2010; 58: 1104-1117.
13. Orthmann-Murphy JL, Freidin M, Fischer E, Scherer SS, Abrams CK: Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. J Neurosci 2007; 27: 13949- 13957.
14. Magnotti LM, Goodenough DA, Paul DL: Functional heterotypic interactions between astrocyte and oligodendrocyte connexins. Glia 2011; 59: 26-34.
15. Bruzzone R, White TW, Paul DL: Connections with connexins: The molecular basis of direct intercellular signaling. Eur J Biochem 1996; 15: 238, 1-27.
16. Sargiannidou I, Markoullis K, Kleopa KA: Molecular mechanisms of gap junction mutations in myelinating cells. Histol Histopathol 2010; 25: 1191-1206.
17. Kleopa KA, Orthmann-Murphy J, Sargiannidou I: Gap junction disorders of myelinating cells. Rev Neurosci 2010; 21: 397-419.
18. Spray DC, Dermietzel R: X-linked dominant Charcot-Marie-Tooth disease and other potential gap-junction diseases of the nervous system. Trends Neurosci 1995; 18: 256-262.
19. Anzini P, Neuberg DH, Schachner M, Nelles E, Willecke K, Zielasek J, Toyka KV, Suter U, Martini R: Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the GJ protein Cx32. J Neurosci 1997; 17: 4545-4551.
20. Scherer SS, Bone LJ, Deschênes SM, Abel A, Balice-Gordon RJ, Fischbeck KH: The role of the GJ protein Cx32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease. Novartis Found Symp 1999; 219: 175-185.
21. Garbern JY: Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis. Cell Mol Life Sci 2007; 64: 50-65.
22. Bugiani M, Al Shahwan S, Lamantea E, Bizzi A, Bakhsh E, Moroni I, Balestrini MR, Uziel G, Zeviani M: GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology 2006; 67: 273-279.
23. Salviati L, Trevisson E, Baldoin MC, Toldo I, Sartori S, Calderone M, Tenconi R, Laverda A: A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease. Neurogenetics 2007; 8: 57-60.
24. Wolf NI, Cundall M, Rutland P, Rosser E, Surtees R, Benton S, Chong WK, Malcolm S, Ebinger F, Bitner-Glindzicz M, Woodward KJ: Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination. Neurogenetics 2007; 8;39-44.
25. Uhlenberg B, Schuelke M, Rüschendorf F, Ruf N, Kaindl AM, Henneke M, Thiele H, Stoltenburg-Didinger G, Aksu F, Topaloglu H, Nürnberg P, Hübner C, Weschke B, Gärtner J: Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 2004; 75: 251-260.
26. Henneke M, Combes P, Diekmann S, Bertini E, Brockmann K, Burlina AP, Kaiser J, Ohlenbusch A, Plecko B, Rodriguez D, Boespflug-Tanguy O, Gärtner J: GJA12 mutations are a rare cause of Pelizaeus-Merzbacher- like disease. Neurology 2008; 70: 748-754.
27. Ruf N, Uhlenberg B: Analysis of human alternative first exons and copy number variation of the GJA12 gene in patients with Pelizaeus- Merzbacher-like disease. Am J Med Genet B Neuropsychiatr Genet 2009; 150B:226-232.
28. Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS: Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus- Merzbacher-like disease. Mol Cell Neurosci 2007; 34: 629-641.
29. Cailloux F, Gauthier-Barichard F, Mimault C, Isabelle V, Courtois V, Giraud G, Dastugue B, Boespflug-Tanguy O: Genotypephenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease. Eur J Hum Genet 2000; 8: 837-845.
30. Gruenenfelder FI, Thomson G, Penderis J, Edgar JM: Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease. J Anat 2011; 19: 33-43.
31. Tanaka H, Ma J, Tanaka KF, Takao K, Komada M, Tanda K, Suzuki A, Ishibashi T, Baba H, Isa T, Shigemoto R, Ono K, Miyakawa T, Ikenaka K: Mice with altered myelin proteolipid protein gene expression display cognitive deficits accompanied by abnormal neuron- glia interactions and decreased conduction velocities. J Neurosci 2009; 29: 8363-8371.
32. Tress O, Maglione M, Zlomuzica A, May D, Dicke N, Degen J, Dere E, Kettenmann H, Hartmann D, Willecke K: Pathologic and phenotypic alterations in a mouse expressing a connexin47 missense mutation that causes Pelizaeus-Merzbacher-like disease in humans. PLoS Genet 2011; 7:e1002146.
33. Dere E, De Souza-Silva MA, Frisch C, Teubner B, Söhl G, Willecke K, Huston J: Connexin30- deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes. Eur J Neurosci 2003; 18: 629-638.
34. Zlomuzica A, Viggiano D, De Souza Silva MA, Ishizuka T, Gironi Carnevale UA, Ruocco LA, Watanabe T, Sadile AG, Huston JP, Dere E: The histamine H1-receptor mediates the motivational effects of novelty. Eur J Neurosci 2008; 27: 1461-1474.
35. Dere E, Huston JP, De Souza Silva MA: The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev. 2007; 31: 673- 704.
36. Bonnet-Dupeyron MN, Combes P, Santander P, Cailloux F, Boespflug-Tanguy O, Vaurs-Barrière C: PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations. Hum Mutat 2008; 29: 1028-1036.
37. Hodes ME, Blank CA, Pratt VM, Morales J, Napier J, Dlouhy SR: Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus- Merzbacher disease. Am J Med Genet 1997; 69: 121-125.
38. Marble M, Voeller KS, May MM, Stevenson RE, Schwartz CE, Simensen RJ: Pelizaeus- Merzbacher syndrome: Neurocognitive function in a family with carrier manifestations. Am J Med Genet A 2007; 143: 442-447.
39. Merzbacher L: Eine eigenartige familiär-hereditäre Erkrankungsform (Aplasia axialis extracorticalis congenita). Ztschr Ges Neurol Psychiatr 1910: 3:1-138.
40. Pelizaeus F: Über eine eigenthümliche Form spastischer Lähmung mit Cerebralerscheinungen auf hereditärer Grundlage (Multiple Sklerose). Arch Psychiatr Nervenkr 1885; 16: 698-710.
41. Seeman P, Paderova K, Benes V Jr, Sistermans EA: A severe connatal form of Pelizaeus Merzbacher disease in a Czech boy caused by a novel mutation (725C 1 A, Ala242Glu) at the 'jimpy(msd) codon' in the PLP gene. Int J Mol Med 2002; 9: 25-29.
42. Wolf NI, Sistermans EA, Cundall M, Hobson GM, Davis-Williams AP, Palmer R, Stubbs P, Davies S, Endziniene M, Wu Y, Chong WK, Malcolm S, Surtees R, Garbern JY, Woodward KJ: Three or more copies of the proteolipid protein gene PLP cause severe Pelizaeus- Merzbacher disease. Brain 2005; 128: 743- 751.
43. Orthmann-Murphy JL, Salsano E, Abrams CK, Bizzi A, Uziel G, Freidin MM, Lamantea E, Zeviani M, Scherer SS, Pareyson D: Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain 2009; 132: 426-438.
44. Hammond RS, Tull LE, Stackman RW: On the delay-dependent involvement of the hippocampusin object recognition memory. Neurobiol Learn Mem 2004; 82: 26-34.
45. Kesner RP, Lee I, Gilbert P: A behavioural assessment of hippocampal function based on a subregional analysis. Rev Neurosci 2004; 15: 333-351.
46. Remondes M, Schuman EM: Role for a cortical input to hippocampal area CA1 in the consolidation of a long-term memory. Nature2004; 431: 699-703.
47. Vago DR, Bevan A, Kesner RP: The role of the direct perforant path input to the CA1 subregion of the dorsal hippocampus in memory retention and retrieval. Hippocampus 2007; 17: 977-987.
48. Vago DR, Kesner RP: Disruption of the direct perforant path input to the CA1 subregion of the dorsal hippocampus interferes with spatial working memory and novelty detection. Behav Brain Res 2008; 189: 273- 283.
49. Nagy JI, Ionescu AV, Lynn BD, Rash JE: Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice. Glia 2003; 44: 205-218.
50. Kamasawa N, Sik A, Morita M, Yasumura T, Davidson KG, Nagy JI, Rash JE: Connexin- 47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: Implications for ionic homeostasis and potassium siphoning. Neuroscience 2005; 136: 65-86.
51. Orthmann-Murphy JL, Abrams CK, Scherer SS: Gap junctions couple astrocytes and oligodendrocytes. J Mol Neurosci 2008; 35: 101- 116.
52. Pannasch U, Vargová L, Reingruber J, Ezan P, Holcman D, Giaume C, Syková E, Rouach N: Astroglial networks scale synaptic activity and plasticity. Proc Natl Acad Sci USA 2011; 17: 8467-8472.
53. Lutz SE, Zhao Y, Gulinello M, Lee SC, Raine CS, Brosnan CF: Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci 2009; 29: 7743-7752.
54. Fields RD: White matter in learning, cognition and psychiatric disorders. Trends Neurosci 2008; 31: 361-370.
55. Burns MN, Siddique J, Fokuo JK, Mohr DC: Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis. Rehabil Psychol 2010; 55: 255-262.
56. Makinodan M, Yamauchi T, Tatsumi K, Okuda H, Takeda T, Kiuchi K, Sadamatsu M, Wanaka A, Kishimoto T: Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 978-985.
57. Kodama Y, Kikusui T, Takeuchi Y, Mori Y: Effects of early weaning on anxiety and prefrontal cortical and hippocampal myelination in male and female Wistar rats. Dev Psychobiol 2008; 50: 332-342.
58. Ono M, Kikusui T, Sasaki N, Ichikawa M, Mori Y, Murakami-Murofushi K: Early weaning induces anxiety and precocious myelination in the anterior part of the basolateral amygdala of male Balb/c mice. Neuroscience 2008; 156: 1103-1110.
59. Parenti R, Cicirata F, Zappalà A, Catania A, La Delia F, Cicirata V, Tress O, Willecke K: Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity. Glia 2010; 58: 1594-1609.
60. Crawford DK, Mangiardi M, Xia X, Lopez- Valdes HE, Tiwari-Woodruff SK: Functional recovery of callosal axons following demyelination: A critical window. Neuroscience 2009; 164: 1407-1421.